Wang et al. showed that hsa-miR-206 inhibited the proliferation and invasion of thyroid cancer by targeting the RAP1B gene and hsa-miR-206 negatively regulated the RAP1B level in PTC cells [16, 17]. The gene discussed is RAP1B; the disease is thyroid cancer.